诺奖效应来了!Treg新公司“吸金”8000万美元,艾伯维、赛诺菲、再生元支持

医药魔方Pro
Oct 29

在2025年诺贝尔生理学或医学奖授予调节性T细胞(Treg)领域的三位科学家后,敏锐的风险资本迅速行动起来。10月28日,致力于胸腺靶向药物开发的生物技术公司Zag Bio宣布公司已完成8000万美元融资。Polaris Partners创立并孵化了Zag Bio,并与T1D Fund共同领投了近期的A轮融资。参与此轮融资的还包括AbbVie Ventures, Sanofi Ventures, ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10